Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis
Autor: | Nobuo Tsuboi, Hoichi Amano, Kentaro Koike, Kotaro Haruhara, Takashi Yokoo, Makoto Ogura |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male Nephrology medicine.medical_specialty Physiology 030232 urology & nephrology Urology Renal function 030204 cardiovascular system & hematology urologic and male genital diseases 03 medical and health sciences 0302 clinical medicine Heavy proteinuria Physiology (medical) Internal medicine Benign nephrosclerosis medicine Humans Risk factor Aged Retrospective Studies Nephrosclerosis Proteinuria medicine.diagnostic_test business.industry Glomerulosclerosis Middle Aged Prognosis medicine.disease Female Renal biopsy medicine.symptom business |
Zdroj: | Clinical and Experimental Nephrology. 24:688-695 |
ISSN: | 1437-7799 1342-1751 |
DOI: | 10.1007/s10157-020-01885-w |
Popis: | Heavy proteinuria at diagnostic renal biopsy has been reported as an independent risk factor for deteriorating renal function in benign nephrosclerosis (BNS). However, studies investigating the relationship between the amount of proteinuria during follow-up and long-term renal prognosis in BNS are limited. This study aimed to assess the relationship between time-averaged proteinuria (TAP) and renal prognosis in BNS. The study participants included 98 patients with biopsy-proven BNS (average age 52 ± 13 years, estimated glomerular filtration rate (eGFR) 53 ± 25 ml/min/1.73 m2, urine protein excretion at baseline 1.34 ± 1.30 g/gCr) from the Jikei University Hospital. Multivariate analysis was used to investigate the effects of TAP and other clinicopathological findings on the risk for renal outcome in biopsy-proven BNS (a 30% decline in eGFR from baseline or end-stage renal disease). Proteinuria was measured every 6 months and the mean value was used as an indicator of TAP. The average observation period was 56 ± 43 months. In the unadjusted model, higher levels of TAP and urinary protein at baseline, glomerulosclerosis, and tubulointerstitial damage were associated with renal prognosis. The adjusted model demonstrated a significant association between TAP and renal outcomes (hazard ratio 5.45, 95% confidence interval 3.02–10.7), which was independent of higher baseline proteinuria, glomerulosclerosis, and tubulointerstitial damage. TAP is an independent risk factor for renal prognosis in patients with BNS, indicating the significance of urinary protein excretion during follow-up for the progression of BNS. Clinicians should understand the importance of follow-up evaluation for proteinuria in patients with BNS. |
Databáze: | OpenAIRE |
Externí odkaz: |